简体
简体中文
繁體中文

ClearShares Ultra-Short Maturity ETF OPER

等待开盘 01-30 09:30:00 美东时间

100.015

+0.009

+0.01%

华盛通华盛通
立即下载
  • 最 高100.04
  • 今 开100.0102
  • 成交量 3152股
  • 最 低 100.00
  • 昨 收 100.0062
  • 总市值 1.40亿
  • 52周最高 100.30
  • 市盈率 --
  • 换手率 0.23%
  • 52周最低 96.118
  • 委 比 0.00%
  • 总股本 140.00万
  • 历史最高 100.30
  • 量 比 0.64
  • 振 幅 0.04%
  • 历史最低 79.7467
  • 每 手 1
  • 风险率 1.24%

个股概要

财务分析

公司资料

相关新闻

分红派息

  • 分时图
  • 日k
  • 周k
  • 月k

相关新闻

更多
  • Hexcel Q4 sales rise 3.7%, beat expectations

    Hexcel Q4 sales rise 3.7%, beat expectations Overview Composite materials maker's Q4 sales rose 3.7%, beating analyst expectations Adjusted EPS for Q4 beat analyst expectations Company increased quarterly dividend by 6% Outlook Hexcel projects 2026 sales of $2.0 bln to $2.1 bln Company expects 2026

    01-29 05:26

  • Conmed Q4 sales rise 7.9%, beat analyst estimates

    Conmed Q4 sales rise 7.9%, beat analyst estimates Overview Medical technology firm's Q4 revenue rose 7.9%, beating analyst expectations Adjusted EPS for Q4 beat analyst expectations Company's international revenue grew 17% yr/yr, boosting overall sales Outlook Conmed expects full-year 2026 revenue b

    01-29 05:12

  • BRIEF-WhatsApp Will Now Charge Ai Chatbots To Operate In Italy - TechCrunch

    BRIEF-WhatsApp Will Now Charge Ai Chatbots To Operate In Italy - TechCrunch Jan 28 (Reuters) - WHATSAPP WILL NOW CHARGE AI CHATBOTS TO OPERATE IN ITALY - TECHCRUNCH Further company coverage: META.O (( Reuters.Briefs@thomsonreuters.com ;))

    01-29 03:23

  • BRIEF-Cytomed Therapeutics Refutes "Misleading" Claims & Reaffirms Clinical Progress

    BRIEF-Cytomed Therapeutics Refutes "Misleading" Claims & Reaffirms Clinical Progress Jan 28 (Reuters) - CytoMed Therapeutics Ltd F98.F : CYTOMED THERAPEUTICS- DOES NOT CLAIM THERAPEUTIC CANDIDATES ARE APPROVED FOR COMMERCIAL USE OR CLINICALLY VALIDATED BEYOND CURRENT DEVELOPMENT STAGE CYTOMED THERAP

    01-29 00:04

  • John Marshall Bancorp posts higher Q4 profit, declares 20% increase in quarterly dividend

    John Marshall Bancorp posts higher Q4 profit, declares 20% increase in quarterly dividend Overview U.S. bank's Q4 net income rose 23.9% yr/yr, driven by strong loan demand Diluted EPS for Q4 increased 27.3% yr/yr Company declared a 20% increase in quarterly cash dividend Outlook Company anticipates

    01-28 22:15

  • Corning Q4 sales rise on optical communications segment

    Corning Q4 sales rise on optical communications segment Overview Materials science innovator's Q4 core sales grew 14% yr/yr Core EPS for Q4 rose 26% yr/yr, exceeding analyst estimates Company upgrades Springboard Plan, targeting $11 bln in additional sales by 2028 Outlook Corning expects Q1 2026 cor

    01-28 20:12

  • BRIEF-Valens Semiconductor Announces Operational Efficiency Plan

    BRIEF-Valens Semiconductor Announces Operational Efficiency Plan Jan 28 (Reuters) - Valens Semiconductor Ltd VLN.N : VALENS SEMICONDUCTOR ANNOUNCES OPERATIONAL EFFICIENCY PLAN VALENS SEMICONDUCTOR LTD: PLAN INCLUDES 10% WORKFORCE REDUCTION ACROSS VARIOUS DEPARTMENTS VALENS SEMICONDUCTOR LTD - ANNOUN

    01-28 19:45

  • BRIEF-AT&T Expects 2026 Adj EPS Between $2.25 To $2.35

    BRIEF-AT&T Expects 2026 Adj EPS Between $2.25 To $2.35 Jan 28 (Reuters) - AT&T Inc T.N : AT&T Q4 REVENUE $33.5 BILLION VERSUS IBES ESTIMATE $32.87 BILLION AT&T Q4 ADJUSTED EPS $0.52 VERSUS IBES ESTIMATE $0.46 AT&T Q4 POSTPAID PHONE NET ADDS 421,000 AT&T OUTLOOK 2026 ADJUSTED EPS $2.25 TO $2.35 VERS

    01-28 19:27

  • BRIEF-Allbirds Streamlines Operations to Support Profitable Growth

    BRIEF-Allbirds Streamlines Operations to Support Profitable Growth Jan 28 (Reuters) - Allbirds Inc BIRD.O : ALLBIRDS STREAMLINES OPERATIONS TO SUPPORT PROFITABLE GROWTH ALLBIRDS INC - TO CLOSE REMAINING FULL-PRICE U.S. STORES BY FEB 2026 ALLBIRDS INC SAYS WILL CONTINUE TO OPERATE TWO OUTLET STORES I

    01-28 19:02

  • BRIEF-Walmart Boosts Pay Potential For Pharmacy Technicians, Elevates 3,000 Roles

    BRIEF-Walmart Boosts Pay Potential For Pharmacy Technicians, Elevates 3,000 Roles Jan 28 (Reuters) - Walmart Inc WMT.O : WALMART INC: ELEVATED 3,000 ROLES TO PHARMACY OPERATIONS TEAM LEAD POSITIONS THAT PAY AN AVERAGE OF $28 AN HOUR - WEBSITE Source text: [ID:] Further company coverage: WMT.O (( Reu

    01-28 18:26